|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||69.97 - 70.62|
|52 Week Range||62.34 - 76.92|
|PE Ratio (TTM)||N/A|
|Expense Ratio (net)||0.62%|
We have highlighted five solid picks from both the ETF and the stock world that were in red over the past week but have a Zacks Rank #1 or 2.
First Trust Advisors L.P. a global exchange-traded fund provider and asset manager, announced that the Mexican pension funds investment regulator, La Comisión Nacional del Sistema de Ahorro para el Retiro , has approved four additional First Trust ETFs for sale to Mexican funded pensions, known as AFORES.
In 2Q17, United Therapeutics’ (UTHR) Remodulin generated revenues of around $158 million, which reflected ~8% growth on a quarter-over-quarter basis.
For the quarter ending March 31, 2017, Abiomed (ABMD) reported revenues close to $124.7 million, which represents a YoY growth of about 30%.
For fiscal 2017, Align Technology (ALGN) expects its 2017 revenues to grow operationally in the range of 15%–25% YoY.
WellCare Health Plans has updated its earnings per share guidance from the previously estimated range of $6.00–$6.25 to the new range of $6.55–$6.80.
Dentsply Sirona’s (XRAY) 1Q17 earnings and revenue failed to meet analysts’ estimates. The company reported a fall in its organic revenue.